Home Blog of Signal Transduction Epigenetics PARP High-fat diet and NAD+ replenishment can rescue Cockayne Syndrome

Category

Archives

Popular Post

ESKM, a novel therapeutic agent for sensitive and resistant PH+ leukemias

The mechanism of resistance to JAK2 inhibitor in myeloproliferative neoplasms patients

Effects of PARP inhibitors in BRCA gene-mutated ovarian cancer

DASATINIB; An inhibitor of Receptor Tyrosine Kinase

GP130/JAK/STAT3 signaling pathway induces multiple myeloma

High-fat diet and NAD+ replenishment can rescue Cockayne Syndrome

 

Cockayne syndrome (CS), inherited in an autosomal recessive pattern, is mainly indentified by impaired development of nervous system and premature aging. This condition is caused by the mutation in genes encoding DNA repair protein, CSA or CSB. Scheibye-Knudsen et al. demonstrated high-fat diet, the inhibition of β-hydroxybutyrate (β-OHB), and the elevation of  NAD+ levels, may have the effect to rescue premature aging through activating Sirtuin1 (SIRT 1) signaling. The article was published on Cell Metabolism.

 

It is well-established that diet is one of the interventions that can affect neurodegenerative process. On Csb mutated Csbm/m mice, researchers conducted a experiment including three treatment: high-fat, caloric-restricted, or resveratrol-supplemented diet. They found high-fat diet can normalize the metabolic disorder and some of the neurological dysfunction without adverse effects on Csbm/m mice. By further investigation, researchers found premature aging in CSB-deficient mice and cells resulted from abnormal activation of poly-ADP-ribose polymerase (PARP), caused a reduction of SIRT1 activity and mitochondrial dysfunction. Also, CSB deficiency led to NAD/NADH equilibrium. Afterwards, researchers noticed that β-OHB, PARP inhibition, or NAD+ replenishment can normalized CS-related phenotypes by activating SIRT1. The study reveals two metabolites, β-OHB and NAD+, may have effect on CS, and provides a novel therapeutic method for the sever incurable syndrome.

 

Reference:
Cell Metabolism. 2014 Nov 4;20(5):840-855.

Related Products

Cat.No. Product Name Information
S1541 Selisistat (EX 527) Selisistat (EX 527, SEN0014196) is a potent and selective SIRT1 inhibitor with IC50 of 38 nM in a cell-free assay, exhibits >200-fold selectivity against SIRT2 and SIRT3. Phase 2.
S1129 SRT1720 HCl SRT1720 HCl is a selective SIRT1 activator with EC50 of 0.16 μM in a cell-free assay, but is >230-fold less potent for SIRT2 and SIRT3. SRT1720 induces autophagy.

Related Targets

PARP Sirtuin